Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01829035
Recruitment Status : Completed
First Posted : April 11, 2013
Last Update Posted : March 29, 2018
Sponsor:
Information provided by (Responsible Party):
Joong-Won Park, National Cancer Center, Korea

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 21, 2017
Actual Study Completion Date : June 21, 2017